CLDX
Celldex Therapeutics Inc.
$24.86
+$0.25(+1.02%)
45
Overall
--
Value
45
Tech
--
Quality
Market Cap
$1.63B
Volume
1.01M
52W Range
$14.40 - $47.00
Target Price
$55.69
EPS Estimates Overview
| Current Quarter | $-0.88 | Next Quarter | $-0.9 |
| Current Year | $-3.42 | Next Year | $-4.47 |
| QoQ Growth | -2.3% | YoY Growth | -30.7% |
| 3Y EPS CAGR | -14.3% | Target Price | $55.69 |
| Consensus | Buy | Upside | +124.0% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CLDX | $24.86 | +1.0% | 1.01M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Celldex Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW